Surveillance after EVAR: Duplex and CEUS in Endoleak Detection and Classification
Why Monitor After EVAR
The endograft does not "cure" the abdominal aortic aneurysm but isolates the sac from pressure. Therefore, lifetime surveillance is necessary to timely detect leak (endoleak), graft migration, or sac expansion. Duplex and contrast-enhanced ultrasound (CEUS) are working tools for surveillance alongside CTA.
Surveillance Protocol
Rule 1. Baseline is established in the first month after EVAR (typically CTA at day 30). Subsequently, in the absence of endoleak and sac growth, transition to annual surveillance with duplex/CTA. Surveillance is lifelong (SVS 2018; ESVS 2019 proposes risk-stratified surveillance). When endoleak is suspected, CEUS is added—it is more sensitive than standard duplex and approaches CTA.
Duplex is increasingly used for routine surveillance in the absence of endoleak or sac expansion, reducing radiation and contrast burden from CTA.
Endoleak: Definition and Classification
Endoleak is persistence of blood flow within the aneurysm sac outside the endograft lumen—that is, the sac is again "under pressure." This is a specific and critical complication of EVAR. Endoleaks are classified anatomically by source of leak (types I–V):
| Type | Source |
|---|---|
| I (Ia/Ib) | Fixation site (proximal Ia / distal Ib) |
| II | From collaterals (retrograde backflow) |
| III | From collaterals / graft component connection defect |
| IV–V | Other [to be clarified] |
Role of CEUS and Microvascular Imaging
CEUS significantly enhances sensitivity to endoleak, particularly type II: in comparative studies, CEUS sensitivity approaches CTA (approximately 91–100%), substantially exceeding standard duplex. Modern microvascular imaging techniques (SMI) are comparable to CEUS in detecting type II endoleak. Emerging technologies such as 4D-CEUS (CEUS with 3D reconstruction and real-time interrogation) and CEUS/CT fusion techniques show promise for even earlier detection and characterization of endoleaks.
Management of Detected Endoleak
According to SVS 2018, type I, II, and III endoleaks are treated when sac growth occurs. With sac expansion or type I/III endoleak, increased surveillance frequency and consideration for reintervention are indicated.
Frequently asked questions
When is baseline established after EVAR?
In the first month—typically CTA at day 30 (SVS 2018). Subsequently, in the absence of endoleak and sac growth, transition to annual duplex/CTA surveillance.
When should CEUS be added to duplex?
When endoleak is suspected: CEUS is more sensitive than standard duplex and approaches CTA, particularly for type II endoleak.
What is the sensitivity of CEUS for endoleak detection?
In comparative studies, CEUS sensitivity approaches CTA—approximately 91–100%, substantially exceeding standard duplex.
How are endoleaks classified?
Anatomically by source of leak—types I–V (with subdivision Ia/Ib; types II and III from collaterals).
Which endoleaks require treatment?
According to SVS 2018, type I, II, and III endoleaks are treated when sac growth occurs; with sac expansion or type I/III endoleak, increased surveillance and consideration for reintervention are indicated.